(Q85274457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

title

Diabetic nephropathy: renoprotective effects of pentoxifylline in the PREDIAN trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

1 reference

1 reference

Tony He

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Mark E Cooper

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

publication date

9 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

16 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

page(s)

547-548

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25201141%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneph.2014.162

16 February 2020

exact match

0 references

cites work

Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162

Changes in diabetes-related complications in the United States, 1990-2010

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162

Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162

Therapeutic approaches to diabetic nephropathy--beyond the RAS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162

The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162

Pentoxifylline for diabetic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2014.162